论文部分内容阅读
Thirteen children with difficult systemic onset juvenile rheumatoid arthritis were treated with thalidomide. At 6 months, 11 of the 13 were able to reduce their use of prednisone (P < .002), with a concurrent improvement in erythrocyte sedimentation rate (P < . 0001) and an increase in hemoglobin level (P < 0. 005). Juvenile rheumatoid arthritis improvement scores ≥ 50% were obtained by 10 of the 13 children.
Thirteen children with difficult systemic onset juvenile rheumatoid arthritis were treated with thalidomide. At 6 months, 11 of the 13 were able to reduce their use of prednisone (P <.002), with a concurrent improvement in erythrocyte sedimentation rate (P <. 0001 ) and an increase in hemoglobin level (P <0. 005). Juvenile rheumatoid arthritis improvement scores ≥ 50% were obtained by 10 of the 13 children.